The Efficacy of Currently Licensed Biologics for Treatment of Ulcerative Colitis: A Literature Review
Article in Cureus (April 2023)
The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.
Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis
Article in ClinicoEconomics and Outcomes Research (February 2023)
Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis
Article in Inflammatory Bowel Diseases (November 2022)